• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[与氨苯恶唑摄入相关的肺动脉高压病例长期调查。9例病例的组织学、定量及形态测量学研究]

[Prolonged survey of cases of pulmonary hypertension in relation to consumption of aminorex. Histological, quantitative and morphometric study of 9 cases].

作者信息

Widgren S

出版信息

Schweiz Med Wochenschr. 1986 Jul 8;116(27-28):918-24.

PMID:3738463
Abstract

The lesions of pulmonary muscular arteries of 9 female patients who died of pulmonary hypertensive disease between 9 and 17 years after intake of an anorexigenic drug, aminorex fumarate, have been examined by various methods (light microscopy, numeration of lesions, morphometry). The numeration of lesions showed the predominance of fibrotic and dilatation lesions, but also the presence of active lesions (intimal hyperplasia, plexiform lesions). Morphometry revealed an increase in mean thickness of the media, compared to that of the arteries of controls or those of a previous series, and a reduction in mean vascular volume. The existence of sclerotic lesions and reduction of vascular volume may explain the persistence of pulmonary hypertension, which fresh lesions helped to aggravate. It seems likely that functional and morphologic modifications due to the action of the drug had become self-perpetuating and may finally have induced the fatal outcome in these patients many years after intake of the slimming pill.

摘要

对9名在服用食欲抑制剂富马酸氨基苯唑9至17年后死于肺动脉高压疾病的女性患者的肺肌性动脉病变进行了多种方法检查(光学显微镜检查、病变计数、形态计量学)。病变计数显示纤维化和扩张性病变占主导,但也存在活动性病变(内膜增生、丛状病变)。形态计量学显示,与对照组或先前系列研究的动脉相比,中膜平均厚度增加,平均血管容积减少。硬化性病变的存在和血管容积的减少可能解释了肺动脉高压的持续存在,而新出现的病变则加剧了这种情况。由于药物作用导致的功能和形态学改变似乎已经自我延续,最终可能在这些患者服用减肥药多年后导致了致命的后果。

相似文献

1
[Prolonged survey of cases of pulmonary hypertension in relation to consumption of aminorex. Histological, quantitative and morphometric study of 9 cases].[与氨苯恶唑摄入相关的肺动脉高压病例长期调查。9例病例的组织学、定量及形态测量学研究]
Schweiz Med Wochenschr. 1986 Jul 8;116(27-28):918-24.
2
Pulmonary hypertension, "plexogenic pulmonary arteriopathy" and the appetite depressant drug aminorex: post or propter?肺动脉高压、“丛状肺血管病”与食欲抑制剂氨基苯唑:因果孰先孰后?
Bull Eur Physiopathol Respir. 1979 Sep-Oct;15(5):897-923.
3
Aminorex and pulmonary hypertension. A review.氨苯恶唑与肺动脉高压。综述
Cor Vasa. 1985;27(2-3):160-71.
4
Pulmonary hypertension related to aminorex intake. Histologic, ultrastructural, and morphometric studies of 37 cases in Switzerland.与氨苯唑啉摄入相关的肺动脉高压。瑞士37例病例的组织学、超微结构及形态测量学研究
Curr Top Pathol. 1977;64:1-64.
5
[Long-term course of primary vascular pulmonary hypertension with and without intake of appetite depressants].[有无服用食欲抑制剂情况下的原发性血管性肺动脉高压的长期病程]
Z Kardiol. 1983 Apr;72(4):215-21.
6
[Chronic pulmonary hypertension of vascular origin, plexogenic pulmonary arteriopathy and the appetite depressant aminorex: addenda to an epidemic].[血管源性慢性肺动脉高压、丛状肺血管病与食欲抑制剂阿米雷司:一种流行病的补遗]
Schweiz Med Wochenschr. 1985 Jun 8;115(23):782-9contd.
7
[Drug-induced primary vascular pulmonary hypertension. Contribution to its etiology and clinical course].[药物性原发性血管性肺动脉高压。对其病因和临床病程的贡献]
Med Welt. 1976 Jun 25;27(26):1300-3.
8
[Thrombocyte behavior in patients with "primary" pulmonary hypertension. Pathogenesis of aminorex-induced pulmonary hypertension].
Acta Med Austriaca Suppl. 1980;19:1-28.
9
[Chronic pulmonary hypertension of vascular etiology, plexogenic pulmonary arteriopathy and the appetite depressant Aminorex: lessons from an epidemic].[血管性病因所致慢性肺动脉高压、丛状肺血管病与食欲抑制剂阿米雷司:一场流行病的教训]
Schweiz Med Wochenschr. 1985 Jun 15;115(24):818-27.
10
[Aminorex-induced, plexogenic pulmonary arteriopathy: 25 years later!].[氨苯恶唑诱导的丛状肺血管病:25年后!]
Z Kardiol. 1993 Sep;82(9):568-72.

引用本文的文献

1
DARK Classics in Chemical Neuroscience: Aminorex Analogues.《化学生物神经科学经典作品:苯丙醇胺类似物》
ACS Chem Neurosci. 2018 Oct 17;9(10):2484-2502. doi: 10.1021/acschemneuro.8b00415. Epub 2018 Oct 5.